PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 1, 2024European Heart Journal54 citationsOpen Access

Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

View Full Paper
JSJessica R. SchubertMLMargrét LeósdóttirBLBertil Lindahl

Key Points

  • High non-HDL-C levels correlate with increased risk of adverse outcomes, indicating their prognostic value after myocardial infarction.
  • Findings show that maintaining lower non-HDL-C levels can improve patient outcomes post-MI, with implications for treatment strategies.
  • Assessment of cholesterol levels was conducted using data from the SWEDEHEART registry, capturing a wide patient demographic post-MI over several years for accuracy and reliability in trends observed in cholesterol levels and outcomes. // Study highlights the necessity for ongoing monitoring, indicating areas for enhanced patient management post-MI.

Abstract

Non-high-density lipoprotein cholesterol (HDL-C) provides an estimate of lipid-associated risk and is a secondary treatment target after myocardial infarction (MI). The aim was to study the relationship between non-HDL-C levels after MI and risk of adverse outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Schubert et al. (2024) studied this question.

synapsesocial.com/papers/68e59b44b6db6435875364c6https://doi.org/10.1093/eurheartj/ehae576
Ask AI
Helpful
Bookmark
Share
View Full Paper